stockcue

ALNY (Alnylam Pharmaceuticals, Inc.): risk score 61/100 — Buy · Valuation 32/100 · Financial health 71/100 · Growth 85/100 · price $293.22. Full report with peer comparison, earnings trends and AI analysis below.

Fetching report — first lookup can take ~5s